Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: A clinical randomized double-blind placebo-controlled trial

Archives of Medical Research

Volumn 45, Issue 4, 2014, Pages 325-330

  Simental Mendía, Luis E ^a,b   Rodríguez Morán, Martha ^a,b   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b The Research Group on Diabetes   (Mexico)

Author keywords

C reactive protein; Hypomagnesemia; Magnesium; Prediabetes

Indexed keywords

BICARBONATE; C REACTIVE PROTEIN; GLUCOSE; HIGH SENSITIVITY C REACTIVE PROTEIN; MAGNESIUM; MAGNESIUM CHLORIDE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPOMAGNESEMIA; IMPAIRED GLUCOSE TOLERANCE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

C-REACTIVE PROTEIN; HYPOMAGNESEMIA; MAGNESIUM; PREDIABETES;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCALCIURIA; MAGNESIUM CHLORIDE; MALE; MIDDLE AGED; NEPHROCALCINOSIS; PREDIABETIC STATE; RENAL TUBULAR TRANSPORT, INBORN ERRORS; YOUNG ADULT;

EID: 84902014026     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.04.006     Document Type: Article

References (24)

1. Guerrero-Romero F., Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002, 26:469-474.
2. Rodriguez-Morán M., Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res 2004, 17:189-196.
3. Guerrero-Romero F., Rodriguez-Moran M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res 2006, 22:471-476.
4. Kramer J.H., Spurney C., Iantorno M., et al. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009, 338:22-27.
5. King D.E., Mainous A.G., Geesey M.E., et al. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005, 24:166-171.
6. Guerrero-Romero F., Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002, 39:209-213.
7. Song Y., Ridker P.M., Manson J.E., et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005, 28:1438-1444.
8. King D.E., Mainous A.G., Geesey M.E., et al. Magnesium intake and serum C-reactive protein levels in children. Magnes Res 2007, 20:32-36.
9. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
10. Simental-Mendía L.E., Rodríguez-Morán M., Reyes-Romero M.A., et al. No positive effect of oral magnesium supplementation in the decreases of inflammation in subjects with prediabetes: a pilot study. Magnes Res 2012, 25:140-146.
11. Follow up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
12. Kisters K., Spieker C., Tepel M., et al. New data about the effect of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993, 6:355-360.
13. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
14. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997, 43:52-58.
15. Almoznino-Sarafian D., Berman S., Mor A., et al. Magnesium and C-reactive protein in heart failure: an anti-inflammatory effect of magnesium administration?. Eur J Nutr 2007, 46:230-237.
16. King D.E., Mainous A.G., Geesey M.E., et al. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005, 24:166-171.
17. Malpuech-Brugère C., Rock E., Astier C., et al. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. Life Sci 1998, 63:1815-1822.
18. Malpuech-Brugère C., Nowacki W., Daveau M., et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000, 1501:91-98.
19. Weglicki W.B., Mak I.T., Phillips T.M. Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res 1994, 74:1009-1013.
20. Gao X., Bermudez O.I., Tucker K.L. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J Nutr 2004, 134:913-918.
21. Larsson A., Hansson L.O., Akerfeldt T. Weight reduction is associated with decreased CRP levels. Clin Lab 2013, 59:1135-1138.
22. Puglisi M.J., Fernandez M.L. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 2008, 138:2293-2296. 10.3945/jn.108.097188.
23. Dansinger M.L., Gleason J.A., Griffith J.L., et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005, 293:43-53.
24. Selvin E., Paynter N.P., Erlinger T.P. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007, 167:31-39.